Srpski

English

العربية

Deutsch

Français

Italiano

Español

Ελληνικά

Türkçe

Srpski

中文
+381 64 251 88 20
+381 64 251 88 20
erdeljan@viderma.co.rs
Top tretmani Tretman Autizma Anti-Aging tretman Tretman srca Tretman diabetesa Tretman multipla skleroze Tretman mišićne distrofije ALS/MND Alchajmerova bolest Anemija Arterijska hipertenzija Kancer Cerebralna paraliza Usporen psih.mot.razvoj Erektivna disfunkcija Parkinsonova bolest Reumatoidni artritis SMA Ulcerativni kolitis. Kronova bolest Male Infertility
Top tretmani Tretman Autizma Anti-Aging tretman Tretman srca Tretman diabetesa Tretman multipla skleroze Tretman mišićne distrofije
See All
ALS/MND Alchajmerova bolest Anemija Arterijska hipertenzija Kancer Cerebralna paraliza Usporen psih.mot.razvoj Erektivna disfunkcija Parkinsonova bolest Reumatoidni artritis SMA Ulcerativni kolitis. Kronova bolest Male Infertility
Hide

Site Menu

Our licences

→
→

Short notice on A. condition after the stem cell therapy

Patient: A.S.
Gender: Female
Age: 9
Country: Serbia
Diagnosis: Type 2 SMA, grade IV S-kyphoscoliosis
Dates of treatment: April 2-3, 2013

We would like to inform you that A. is great, she is progressing nicely. She has gained the weight and reached 19 kg, eating alone, brushes her teeth alone, so we are looking forward to her next therapy. We believe that she will be even better.

Best regads from S. family from Belgrade.

Rezultat tretmana fetalnim matičnim ćelijama zavisi od: težine bolesti, starosne dobi pacijenta, doslednosti i privrženosti medikaciji i režimu. Rezultati tretmana, prezentovani na ovom sajtu, su individualni za svaki klinički slučaj.
Naši kontakti

Viderma d.o.o.

E-mail adresa: erdeljan@viderma.co.rs

Naša adresa:

Gagarinova 10/G​, 21000 ​ ​Novi Sad, ​ ​Serbia​

Fiksni:

+381 21 443 3 84

Fax:

+381 21 477 0 239

Mobilni:

+381 64 251 88 20
wechat
English
© 1999-2020 EmCell.com